Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. hormone release
Show results for
Products
Services

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Hormone Release Articles & Analysis

5 news found

CD Formulation Introduces Comprehensive Range of Microsphere and Microneedle Solutions for Pharma and Biotech Applications

CD Formulation Introduces Comprehensive Range of Microsphere and Microneedle Solutions for Pharma and Biotech Applications

Microspheres are tiny spherical particles containing drugs that can be injected or implanted for sustained release, allowing a slow and controlled delivery of the therapeutic agent to the targeted site. ...

ByCD Formulation


Lumos Pharma Announces a Clinical Collaboration with Massachusetts General Hospital (MGH) to Evaluate Oral LUM-201 in Nonalcoholic Fatty Liver Disease (NAFLD) in a Phase 2 Investigator-Initiated Trial

Lumos Pharma Announces a Clinical Collaboration with Massachusetts General Hospital (MGH) to Evaluate Oral LUM-201 in Nonalcoholic Fatty Liver Disease (NAFLD) in a Phase 2 Investigator-Initiated Trial

"Prior studies have demonstrated growth hormone’s potential to treat NAFLD, given the hormone’s lipolytic actions in addition to its role as an anti-inflammatory cytokine. ...

ByLumos Pharma


The Sunday Times - Sir Richard Branson & co pick their start-ups of 2019

The Sunday Times - Sir Richard Branson & co pick their start-ups of 2019

These are the start-ups that most impressed Britain’s top entrepreneurs and investors in 2019. There was a technology theme to the selections, while several on our panel of small business champions picked companies, they claimed were tackling some of the world’s biggest problems by treating Alzheimer’s disease and broadening access to education. ...

ByNeurovalens Limited


Zucara Therapeutics Doses First Subject in Phase 1 Trial of ZT-01

Zucara Therapeutics Doses First Subject in Phase 1 Trial of ZT-01

ZT-01 is designed to prevent hypoglycemia in people with T1D by restoring the normal glucagon response. Glucagon is a hormone which stimulates the release of glucose from the liver when blood sugar levels drop too ...

ByZucara Therapeutics Inc.


Zucara Therapeutics Doses First Subject in Phase 1 Trial of ZT-01

Zucara Therapeutics Doses First Subject in Phase 1 Trial of ZT-01

ZT-01 is designed to prevent hypoglycemia in people with T1D by restoring the normal glucagon response. Glucagon is a hormone which stimulates the release of glucose from the liver when blood sugar levels drop too ...

ByZucara Therapeutics Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT